Efficiency of treatment with galactoside-specific lectin from mistletoe against rat glioma

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1011-1014

  Lenartz, D ^a   Andermahr, J ^a   Plum, G ^b   Menzel, J ^a   Beuth, J ^b  

^a KLINIKUM CHEMNITZ   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Fischer 344 rats; Galactoside specific mistletoe lectin (ML 1) cytotoxicity; Glioma cells; Immunomodulation; Spheroid model

Indexed keywords

VISCUM ALBUM LECTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOTOXICITY; DRUG EFFICACY; EXPERIMENTAL NEOPLASM; GLIOMA; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME;

ANIMALS; GLIOMA; MALE; NECROSIS; PLANT PREPARATIONS; PLANT PROTEINS; RATS; RATS, INBRED F344; TOXINS, BIOLOGICAL;

EID: 0031840920     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Heiny BM, Beuth J: Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces ß-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 14: 1339-1342, 1994.
2. Beuth J, Ko HL, Tunggal L, Steuer MK, Geisel J, Jeljaszewicz J, Pulverer G: Thymocyte proliferation and maturation in response to galactoside-specific mistletoe Iectin-1. In vivo 7: 407-410, 1993.
3. Lenartz D, Herrmann S, Pietsch T, Rommel T, Menzel J, Beuth J: Cytotoxic activity of the galactoside-specific lectin from mistletoe on anaplastic glioma cell spheroids and cell cultures. Z Onkol/J of Oncol 29: 11-15,1997.
4. Beuth J: Clinical relevance of immunoactive mistletoe lectin-1. Anti Cancer Drugs 8: 53-55, 1997.
5. Beuth J, Stoffel B, Ko HL, Jeljaszewicz J, Pulverer G: Mistellektin-1: neue therapeutische Perspektiven in der Onkologie. Onkologie 18: 36-40, 1995.
6. Steuer MK, Bonkowsky V, Struk J, Beuth J, Kau RJ, Ambrosch P, Neiss A, Kuhn A, Arnold W, Pulverer G, Ko HL: Immundefizienz bei Patienten mit Kopf-Hals-Plattenepithelkarzinomen: Eine rationale Grundlage fur den Einsatz des Immunmodulators ML-1. Otorhinolaryngol Nova 4: 152-159, 1994.
7. Lenartz D, Stoffel B, Menzel J, Beuth J: Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive treatment in glioma patients. Anticancer Res 16: 3799-3802, 1996.
8. Stoffel B, Kramer K, Mayer H, Beuth J: Immunomodulating efficacy of combined administration of galacloside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice. Anticancer Res 17: 1893-1896, 1997.
9. Beuth J, Ko HL, Tunggal L: Einfluss von wassrigen, auf Mistellektin-1 standardisierten Mistelextrakten auf die in vitro (Tumor) Zellproliferation. Dtsch Zschrft Onkol 26: 1-6, 1994.
10. Salman M: Epidemiology and factors affecting survival. In: Apuzzo MLJ (ed) Malignant cerebral glioma. American Assoc of Neurological Surgeons, Park Ridge II, USA, 95-110, 1990.
11. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of postradiotherapy adjuvant chemotherapy with CCNN, procarbazine, and vincristine (PVC) over BCNN for anaplastic gliomas. Int J Radiat Oncol Phys Biol 18: 32, 1990.
12. Samtleben R, Kiefer M, Luther P: Characterization of the different lectins from Viscum album (mistletoe) and their structural relationship with the agglutinins from Abrus precatorius and Ricinus communis. Lectins 4: 617-626, 1985.
13. Pellegrino, LJ, Pellegrino AS, Cushman AJ: A stereotactic atlas of the rat brain. Plenum Press, New York, USA 1979.
14. Gunderson H, Jensen EB: The efficiency of systematic sampling in stereology and its predication. J. Microscopy 147: 229-263, 1997.
15. Hulsen H, Doser C, Meschelke F Differences in the in vitro effectiveness of preparations produced from mistietoes of various host trees. Arzneim Forsch/Drug Res 36: 433-436,1986.
16. Bussing A, Schietzel M: Viscum album L: Indivduelle Immunreaktion und spezifische zytotoxische Effekte, Konsequenzen fur die konventionelle zytostatische Therapie? Dtsch Zschrft Onkol 27: 29-35, 1995.
17. Beuth J, Gabius H-J, Steuer MK, Geisel J, Steuer M, Ko HL, Pulverer G: Enfluss der Misteltherapie auf den Serumspiegel definierter Serumproteine (Akutphaseproteine) bei Tumorpatienten. Med Klinik 88: 287-290, 1993.
18. Beuth J, Ko HL, Gabius H-J, Burrichter H, Oette K, Pulverer G: Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Investig 70: 658-661, 1992.